0001104659-20-009274.txt : 20200131 0001104659-20-009274.hdr.sgml : 20200131 20200131161558 ACCESSION NUMBER: 0001104659-20-009274 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200131 FILED AS OF DATE: 20200131 DATE AS OF CHANGE: 20200131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMillan Ellida CENTRAL INDEX KEY: 0001604617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 814-01064 FILM NUMBER: 20565274 MAIL ADDRESS: STREET 1: C/O ALCENTRA CAPITAL CORP., 200 PARK AVE STREET 2: 7TH FL CITY: NEW YORK STATE: NY ZIP: 10166 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alcentra Capital Corp CENTRAL INDEX KEY: 0001578620 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-922-8240 MAIL ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Alcentra Capital Corp. DATE OF NAME CHANGE: 20130605 4 1 tm206267d3_4.xml OWNERSHIP DOCUMENT X0306 4 2020-01-31 1 0001578620 Alcentra Capital Corp ABDC 0001604617 McMillan Ellida C/O ALCENTRA CAPITAL CORPORATION 200 PARK AVENUE, 7TH FLOOR NEW YORK NY 10166 0 1 0 0 CFO, COO, Treas. & Secretary Common Stock 2020-01-31 4 D 0 2600 D 0 D On January 31, 2020, pursuant to an Agreement and Plan of Merger dated as of August 12, 2019 (as amended on September 27, 2019, the "Merger Agreement"), Alcentra Capital Corporation ("Alcentra Capital") and Crescent Capital BDC, Inc. ("Crescent Capital BDC") effected a merger pursuant to which Crescent Capital BDC (following its reincorporation by merger into the State of Maryland) acquired all of the outstanding shares of Alcentra Capital's common stock in a multi-step stock and cash transaction (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Alcentra Capital common stock was converted into the right to receive (1) 0.4041 shares of Crescent Capital BDC common stock and (2) $2.3784 in cash. /s/ Steven Levinson, attorney-in-fact 2020-01-31